home / stock / lgnd / lgnd news


LGND News and Press, Ligand Pharmaceuticals Incorporated From 10/29/20

Stock Information

Company Name: Ligand Pharmaceuticals Incorporated
Stock Symbol: LGND
Market: NASDAQ
Website: ligand.com

Menu

LGND LGND Quote LGND Short LGND News LGND Articles LGND Message Board
Get LGND Alerts

News, Short Squeeze, Breakout and More Instantly...

LGND - Notable earnings before Friday's open

[[ABBV]], [[AON]], [[AXL]], [[BAH]], [[BR]], [[CBOE]], [[CHTR]], [[CL]], [[CVX]], [[FBP]], [[FLIR]], [[FTS]], [[GT]], [[HON]], [[IPGP]], [[ITT]], [[KKR]], [[LEA]], [[LGND]], [[LHX]], [[LYB]], [[MMP]], [[MO]], [[NVT]], [[NWL]], [[PBI]], [[PEG]], [[PNM]], [[PNW]], [[POR]], [[PQG]], [[PSX]], [[P...

LGND - Ligand's Captisol Technology Plays Key Role in the Manufacture of Gilead's Veklury, the First FDA-Approved COVID-19 Treatment

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today highlighted the company’s role in the manufacturing of Veklury ® (remdesivir), Gilead Sciences’ antiviral drug for the treatment of patients with COVID-19 requiring hospitalization. Veklury is formulated...

LGND - IPO Update: NLS Pharmaceutics Readies $20 Million IPO Plan

NLS Pharmaceutics has filed to raise $20 million in a U.S. IPO. The firm is advancing treatments for narcolepsy and ADHD. NLSP is thinly capitalized and has made no apparent progress on beginning trials for its lead candidate, so I'll pass on the IPO. For further details see...

LGND - Ligand Provides Highlights from Today's Investor Day Event

Updates 2020 Guidance Introduces Preliminary Financial Outlook for 2021 to 2023 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that at today’s virtual Investor Day event its senior management reviewed recent business progress and prov...

LGND - Ligand's Third Quarter Financial Results to be Reported October 30th

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report third quarter 2020 financial results on October 30, 2020. Ligand’s CEO John Higgins, President and COO Matt Foehr, and Executive Vice President and CFO Matt Korenberg will host th...

LGND - Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million Deal

HitGen will acquire Vernalis Limited, a Cambridge, UK CRO, from Ligand Pharmaceuticals for $25 million. Singapore's ASLAN Pharmaceuticals announced plans to develop ASLAN003, its next-gen dihydroorotate dehydrogenase inhibitor in autoimmune conditions, such as multiple sclerosis. ...

LGND - Wall Street Breakfast: The Week Ahead

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week aheadThe earnings season heats up next week, with high-fliers Netflix (NASDAQ:NFLX), Tesla (NASDAQ:TSLA) and Chipotle (NYSE:CM...

LGND - Stocks To Watch: GM's Hummer Charges The EV Party, Earnings Blitz

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...

LGND - Seeking Alpha Catalyst Watch

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

LGND - Most Heavily Shorted Stocks: October 2020

This article presents a list of stocks with the highest short interest as a percentage of shares outstanding. An unprecedented year amid the COVID-19 pandemic driving historic volatility has represented significant trading opportunities for short-sellers. We analyze key trends and...

Previous 10 Next 10